Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs
Summary Google DeepMind’s spinoff, Isomorphic Labs, is approaching the launch of human trials for AI-designed drugs. Colin Murdoch, the chief business officer, stated that the company is preparing to transition…
